La Jolla, CA, United States of America

Keiichiro Suzuki

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: The Salk Institute. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keiichiro Suzuki. Retrieved from https://idiyas.com/inventor/keiichiro-suzuki-wnamastd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Genome Editing by Keiichiro Suzuki

Introduction

Keiichiro Suzuki is a prominent inventor based in La Jolla, CA (US). He has made significant contributions to the field of genome editing, particularly in non-dividing cells. With a total of 2 patents, his work is paving the way for advancements in genetic engineering.

Latest Patents

Suzuki's latest patents focus on methods and compositions for genome editing in non-dividing cells. These patents disclose homology-independent targeted integration methods that allow for the integration of an exogenous DNA sequence into the genome of a non-dividing cell. The methods involve contacting the non-dividing cell with a composition that includes a targeting construct comprising the exogenous DNA sequence and a targeting sequence, along with a complementary strand oligonucleotide homologous to the targeting sequence and a nuclease. This innovative approach alters the genome of the non-dividing cell effectively.

Career Highlights

Keiichiro Suzuki is affiliated with The Salk Institute, where he conducts his research. His work is instrumental in advancing the understanding and application of genome editing technologies.

Collaborations

Some of his notable coworkers include Juan Carlos Izpisua Belmonte and Yuji Tsunekawa. Their collaborative efforts contribute to the innovative research being conducted at The Salk Institute.

Conclusion

Keiichiro Suzuki's contributions to genome editing represent a significant leap forward in genetic research. His innovative methods and compositions are set to impact the future of genetic engineering and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…